The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma

The objectives of the 2020 workshop included discussing the latest scientific developments in plasma cell disorders (PCDs) with an emphasis on the immunology and molecular biology, presenting the most current clinical trial results with MRD and IP data, understanding regulatory issues regarding the use of novel endpoints in clinical trial design and drug approval, discussing novel strategies for MRD and IP testing and encouraging investigators and trainees from around the world to interact with experts in the field of PCDs.

Source: Biology of Blood and Marrow Transplantation - June 6, 2021 Category: Hematology Authors: Sarah A. Holstein, Nizar Bahlis, P. Leif Bergsagel, Manisha Bhutani, Niccolo Bolli, Carrie Brownstein, Pierre Demolis, David Foureau, Francesca Gay, Irene M. Ghobrial, Nicole Gormley, Jens Hillengass, Martin Kaiser, Marcela V. Maus, J. Joseph Melenhorst, Source Type: research